6June - 2020TECH OUTLOOKEditorialStacey Smith Editor-in-Chiefeditor@pharmatechoutlook.comThe CRO industry has grown from providing limited clinical trial services in the 1970s to a full-service industry characterized by a broad relationship with clients and service offerings that encompasses the entire drug development process. Today, CROs provide a comprehensive range of clinical services, including protocol design and management and monitoring of Phase I through Phase IV clinical trials, data management, laboratory testing, medical and safety reviews, and statistical analysis. Besides, CROs also help generate high quality and timely data in support of applications for regulatory approval of new drugs or reformulations of existing drugs as well as new and existing marketing claims. The global CRO market is currently witnessing an increased adoption of digitization in the form of eClinical solutions, using AI and machine learning-based platforms, providing an opportunity for several CROs to position themselves in the segment. Several technology-focused CROs are now developing in-house expertise, which is changing the global clinical trial paradigm with the implementation of adaptive, virtual, and remote clinical trials. Such companies are also moving toward an embedded business model by integrating their services with that of the sponsor's business strategy, thereby supporting as an end-to-end solution provider. Alongside, CROs are now expanding their addressable market through increased breadth and depth of solutions across the entire drug development life cycle. Highlighting these new developments, this edition of Pharma Tech Outlook features some of the most prominent CROs that are transforming the pharmaceutical industry with their innovative services. This issue also provides a combination of thought leadership from subject-matter experts with real-life stories on fostering robust partnerships and exclusive insights from C-level executives. We hope this edition will provide you with the assistance you need in choosing a capable partner that caters to your unique requirements. Let us know your thoughts!The Evolving Pharmaceutical CRO LandscapeCopyright © 2020 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.JUNE - 04 - 2020, Vol 06 - Issue 09 (ISSN 2644-2787) Published by ValleyMedia, Inc. To subscribe to Pharma Tech OutlookVisit www.pharmatechoutlook.com *Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffEditor-in-ChiefStacey SmithVisualizerAsher BlakeEditorial StaffAaron Pierce Ava GarciaJenna VegasCarolynn Walters Justin SmithPaul BarberSalesBrian Thomasbrian@pharmatechoutlook.comPhone: 510.556.2402sales@pharmatechoutlook.comeditor@pharmatechoutlook.commarketing@pharmatechoutlook.comEmail:Contact Us:Phone:510.556.2402, Fax:510-894-8405Jaxon JaseTECH OUTLOOKTECH OUTLOOK
< Page 5 | Page 7 >